Table 3 Frequency of falls risk increasing medication use for single versus multiple falls
Medication/classification | Residents with 1 fall (n = 56 residents) N (%) | Residents with >1 fall (n = 49 residents) N (%) |
|---|---|---|
Benzodiazepine receptor agonists | 16 (28) | 22 (44) |
Antihypertensive drugs | Â | Â |
 Beta-adrenergic antagonists | 16 (29) | 14 (30) |
 Calcium-channel antagonists | 15 (27) | 6 (13) |
 Diuretics | 16 (29) | 20 (43) |
 Renin–angiotensin–aldosterone system inhibitors | 20 (36) | 19 (40) |
Antidepressants* | Â | Â |
 Serotonin reuptake inhibitors | 16 (29) | 23 (47) |
 Trazodone | 6 (11) | 9 (19) |
 Tricyclic and other norepinephrine-reuptake inhibitors | 3 (5) | 2 (4) |
 Serotonin and norepinephrine-reuptake Inhibitors | 2 (4) | 2 (4) |
 Mirtazapine | 5 (9) | 4 (9) |
Antipsychotics* | Â | Â |
 Typical | 0 (0) | 2 (4) |
 Atypical | 11 (20) | 17 (35) |
Narcotics | 15 (27) | 10 (21) |
Digoxin | 2 (4) | 2 (4) |
Anticholinergics | 4 (7) | 5 (10) |